Physician profile
Michael Schallmo
NPI 1407484280
$8,073.27
in general payments reported to CMS, 2019-2025
10 companies · $582 in 2025
The $582 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $1,217 · 2021: $4,192 · 2022: $52.05 · 2023: $383 · 2024: $1,646 · 2025: $582.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,809 · Travel and Lodging: $803.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,808.64 |
| Travel and Lodging | $802.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Peerless Surgical INC. | $4,862.48 | 2020-2021 | |
| Icotec Medical INC. | $1,096.15 | 2024 | Icotec Blackarmor Spine System |
| Globus Medical, INC. | $705.91 | 2021-2025 | Reline, Xlif |
| Medtronic, INC. | $303.56 | 2023-2024 | Mazor X System, Cd Horizon Spinal System |
| Depuy Synthes Sales INC. | $266.75 | 2022-2024 | Expedium, Conduit, Expedium Verse |
| Stryker Corporation | $260.60 | 2024-2025 | Variax, Core, Prolift |
| Kuros Biosciences USA, INC | $188.34 | 2025 | Magnetos |
| Integra Lifesciences Corporation | $168.30 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Orthofix Medical, INC. | $120.49 | 2023 | Physio-Stim, Spinal-Stim |
| Osteoremedies, LLC | $100.69 | 2024 | Osteoboost Select 10cc, Biobrush, Biowash Surgical Irrigation |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Schallmo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.